Industry Focus
Healthcare: What's The Most Important Number In Gilead Sciences Earnings Report?
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:15:25
- Mas informaciones
Informações:
Sinopsis
Motley Fool analysts dig into Teva Pharmaceuticals recent M&A and debate the single most important number reported in Gilead Sciences second quarter earnings results.
